Suppr超能文献

张力障碍状态:综合征及其管理

Status dystonicus: the syndrome and its management.

作者信息

Manji H, Howard R S, Miller D H, Hirsch N P, Carr L, Bhatia K, Quinn N, Marsden C D

机构信息

Royal Free Hospital, London, UK.

出版信息

Brain. 1998 Feb;121 ( Pt 2):243-52. doi: 10.1093/brain/121.2.243.

Abstract

Patients with dystonic syndromes sometimes develop increasingly frequent and relentless episodes of devastating generalized dystonia which we call status dystonicus. Twelve cases of status dystonicus, of various underlying aetiologies, are presented. Possible precipitating factors were identified in only five cases: intercurrent infection (one); discontinuation of lithium (one) and tetrabenazine (one); and the introduction of clonazepam (two). Nine patients required mechanical ventilation and three others were sedated with intravenous chlormethiazole. Drug therapy used included benzhexol, tetrabenazine, pimozide, baclofen, chlorpromazine, haloperidol, carbamazepine and acetozolamide. Two patients underwent thalamotomies, one of whom improved. Two patients died, five returned to their pre-status dystonicus condition, two eventually made a full recovery and three were worse. Patients with status dystonicus should be managed on an intensive care unit as they may develop bulbar and respiratory complications which may require ventilation. Metabolic problems encountered can include rhabdomyolysis with acute renal failure. Drug therapy with benzhexol, tetrabenazine and pimozide or haloperidol may be beneficial in some cases.

摘要

患有肌张力障碍综合征的患者有时会出现越来越频繁且难以控制的严重全身性肌张力障碍发作,我们称之为肌张力障碍状态。本文介绍了12例不同病因的肌张力障碍状态病例。仅在5例中确定了可能的诱发因素:并发感染(1例);停用锂盐(1例)和丁苯那嗪(1例);以及开始使用氯硝西泮(2例)。9例患者需要机械通气,另外3例用静脉注射氯美噻唑镇静。使用的药物治疗包括苯海索、丁苯那嗪、匹莫齐特、巴氯芬、氯丙嗪、氟哌啶醇、卡马西平和乙酰唑胺。2例患者接受了丘脑切开术,其中1例病情改善。2例患者死亡,5例恢复到肌张力障碍状态前的状况,2例最终完全康复,3例病情恶化。肌张力障碍状态患者应在重症监护病房进行治疗,因为他们可能会出现延髓和呼吸并发症,可能需要通气。遇到的代谢问题可能包括横纹肌溶解伴急性肾衰竭。在某些情况下,使用苯海索、丁苯那嗪和匹莫齐特或氟哌啶醇进行药物治疗可能有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验